Variant report
Variant | esv3457419 |
---|---|
Chromosome Location | chr11:19111284-19111683 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78549850 | chr11:19111295-19111296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76874134 | chr11:19111309-19111310 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72889773 | chr11:19111313-19111314 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs532341894 | chr11:19111332-19111333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368383426 | chr11:19111346-19111347 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547250571 | chr11:19111358-19111359 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372496489 | chr11:19111398-19111399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377207731 | chr11:19111403-19111404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535995799 | chr11:19111407-19111408 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376341181 | chr11:19111408-19111409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573071614 | chr11:19111415-19111416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187550847 | chr11:19111418-19111419 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192748002 | chr11:19111428-19111429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533510275 | chr11:19111435-19111436 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553260387 | chr11:19111483-19111484 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112155438 | chr11:19111488-19111489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112670572 | chr11:19111493-19111494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182855930 | chr11:19111494-19111495 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111593134 | chr11:19111498-19111499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374560852 | chr11:19111501-19111502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11826185 | chr11:19111524-19111525 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs112566384 | chr11:19111549-19111550 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7927007 | chr11:19111559-19111560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555613732 | chr11:19111564-19111565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542777478 | chr11:19111580-19111581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113221303 | chr11:19111587-19111588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561334430 | chr11:19111588-19111589 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142258543 | chr11:19111605-19111606 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370472710 | chr11:19111611-19111612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534472436 | chr11:19111619-19111620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150912524 | chr11:19111623-19111624 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191911808 | chr11:19111627-19111628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540588925 | chr11:19111661-19111662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs16936126 | chr11:19111668-19111669 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Lung cancer | 17086460 | CNVD |
Uterine serous papillary cancer | 19536090 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:19104800-19111800 | Weak transcription | Esophagus | oesophagus |
2 | chr11:19108200-19113400 | Enhancers | HUVEC | blood vessel |
3 | chr11:19109800-19111800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr11:19110000-19112000 | Weak transcription | NH-A | brain |
5 | chr11:19110000-19115400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr11:19110400-19112800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr11:19110600-19112000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr11:19110800-19111400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr11:19110800-19112000 | Enhancers | NHEK | skin |